1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Many Bright Ideas Technologies Inc.

Many Bright Ideas Technologies Inc.

MBGNF
Many Bright Ideas Technologies Inc.US flagOther OTC
0.01
USD
- -
- -
101,821.00Market Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.05
-0.1
-0.04
-0.04
- -
-0.04
-0.01
-0.01
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
-0.04
-0.05
-0.03
-0.01
- -
- -
- -
-0.01
0.01
-0.01
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.56
-0.61
-0.61
-0.6
-1.62
-0.62
-0.63
-0.48
-0.41
-0.36
-0.32
-0.32
-0.32
-0.32
Tangible Book Value per Share
0.04
0.01
- -
-0.01
- -
-0.01
-0.02
- -
-0.01
-0.01
- -
-0.01
-0.01
-0.01
Basic Weighted Avg Shares
8
8
8
9
9
9
9
11
13
15
17
17
17
17
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
-0.24
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
17
17
17
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
196.32%
49.76%
32.72%
Free Cash Flow
58.61%
-239.64%
-521.16%
Net Income, GAAP
-175.69%
-2.74%
-6.88%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Iain Weir-Jones
Full Time Employees
7
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Address
598 East Kent Avenue South Vancouver BC Canada V5X 4V6
IPO Date
Aug 24, 2018
Website
medbiogene.com
Similar Companies
Mettler-Toledo International Inc. (0K10.L)
Immunovia AB (publ) (0G8X.L)
Lumos Diagnostics Holdings Limited (LDXHF)
Integrated Diagnostics Holdings plc (IDGXF)
Danaher Corporation (DHR-PB)
Eurofins Scientific SE (ESF.VI)
Business
Many Bright Ideas Technologies Inc. (Ticker: MBGNF) operates primarily in the biotechnology and medical technology sector, specializing in the development, manufacturing, and commercialization of advanced biotechnological products and medical devices. The company offers a comprehensive range of core products and services including biopharmaceuticals, gene therapies, medical diagnostics, and personalized medicine solutions. Its product categories span novel therapeutic platforms, molecular diagnostic kits, biologic drugs, and cutting-edge medical devices aimed at improving patient outcomes across various therapeutic areas. Many Bright Ideas Technologies engages in research and development (R&D), manufacturing, and distribution of these biotechnological and medical products in North America, Europe, and select Asian markets. The company was founded in 2006 and is headquartered in Toronto, Canada. It has cultivated strategic partnerships with leading research institutions and industry players to accelerate innovation and expand its market share globally. In the last 1-2 years, Many Bright Ideas Technologies has made significant strides by entering multiple strategic alliances to enhance its product pipeline and global footprint. It recently launched a new line of gene-editing therapies tailored for rare genetic disorders and expanded its diagnostics business by introducing highly sensitive molecular diagnostic tools. Additionally, the company completed a funding round to support its R&D efforts and acquired a smaller biotech firm specializing in RNA-based therapeutics, further strengthening its position in the gene therapy market. These developments reflect the company's ongoing focus on innovation, diversification, and international expansion in the biotechnology field.